TABLE 1

Baseline characteristics after propensity weighting

CharacteristicCorticosteroidsNo corticosteroidsSMD
Subjects1147.93740.15
Age at admission, years58.52±11.8958.50±12.600.002
SexMale741.6 (64.6)479.2 (64.7)0.003
Female406.3 (35.4)261.0 (35.3)
EthnicityWhite862.8 (75.2)558.3 (75.4)0.008
South Asian118.2 (10.3)76.2 (10.3)
Black83.5 (7.3)53.4 (7.2)
Other83.4 (7.3)52.3 (7.1)
IMD quintile1 – most deprived262.4 (22.9)169.1 (22.9)0.008
2269.6 (23.5)172.6 (23.3)
3202.5 (17.6)132.8 (17.9)
4196.2 (17.1)126.6 (17.1)
5 – least deprived217.1 (18.9)139.0 (18.8)
ObesityYes – BMI ≥30 kg·m−2683.3 (59.5)440.1 (59.5)0.001
No – BMI <30 kg·m−2464.6 (40.5)300.0 (40.5)
Smoking statusNever642.7 (56.0)412.0 (55.7)0.007
Ex-smoker484.6 (42.2)314.3 (42.5)
Current smoker20.7 (1.8)13.8 (1.9)
Number of comorbidities1.48±1.371.49±1.400.005
Number of comorbiditiesNo comorbidity342.2 (29.8)222.1 (30.0)0.013
1 comorbidity308.5 (26.9)202.2 (27.3)
2+ comorbidities497.2 (43.3)315.8 (42.7)
Cardiovascular comorbiditiesYes562.6 (49.0)361.6 (48.9)0.003
No585.4 (51.0)378.6 (51.1)
Metabolic/endocrine/renal comorbiditiesYes314.7 (27.4)198.8 (26.9)0.012
No833.2 (72.6)541.4 (73.1)
Respiratory comorbiditiesYes292.3 (25.5)190.1 (25.7)0.005
No855.6 (74.5)550.1 (74.3)
Type 2 diabetesYes238.5 (20.8)151.4 (20.5)0.008
No909.4 (79.2)588.8 (79.5)
Neurological/psychiatric comorbiditiesYes52.1 (4.5)31.8 (4.3)0.012
No1095.8 (95.5)708.4 (95.7)
WHO clinical progression scale statusWHO scale 5603.3 (52.6)388.1 (52.4)0.002
WHO scale 6335.0 (29.2)216.3 (29.2)
WHO scale 7–9209.6 (18.3)135.7 (18.3)

Data are n, n (%) or mean±sd. Percentages are calculated by category after exclusion of missing data for that variable. BMI: body mass index; IMD: index of multiple deprivation; SMD: standardised mean difference; WHO: World Health Organization.